BostonGene Receives Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
SAN ANTONIO , July 22, 2025 /CNW/ -- Frost & Sullivan has named BostonGene the recipient of the 2025 North American Enabling Technology Leadership Award in recognition of the company's pioneering role in advancing precision oncology. BostonGene's clinically validated, AI-powered platform uses a multimodal approach to decode disease and uncover predictive biological signatures.
BostonGene combines data from genes, RNA, proteins, the immune system and the tumor environment to help pharma and biotech develop targeted therapies, design efficient trials, and improve outcomes. Its "Comprehensive Digital Patient" model enables precise drug targeting, biomarker validation and patient stratification. With high test success and fast turnaround, BostonGene accelerates data-driven clinical decisions.
"BostonGene has developed state-of-the-art AI-driven, next-generation analytics technologies and is the only known source capable of delivering such comprehensive and integrated analyses," said Unmesh Lal , Healthcare Research Director at Frost & Sullivan. "What truly differentiates BostonGene is its ability to turn vast, complex datasets into clinically meaningful insights with speed and accuracy—delivering real impact not just in research settings but in real-world clinical and drug development environments where timely, actionable data is critical."
Backed by a decade of scientific investment and a growing intellectual property portfolio, BostonGene's capabilities span internal lab services, advanced analytics and multimodal assay integration. Its CLIA-certified, CAP-accredited and NYS-approved regulatory infrastructure ensures quality and compliance across global partnerships.
"By delivering tailored solutions, accelerating project timelines and driving innovation through advanced analytics, BostonGene is fundamentally transforming oncology drug development," said Manuel Albornoz , Best Practices Research Analyst at Frost & Sullivan. "Its adaptability, speed and scientific rigor make it a trusted partner for the industry."
"This recognition reinforces our commitment to equipping drug developers with the tools they need to make smarter, faster decisions," said Nathan Fowler , MD, Chief Medical Officer at BostonGene. "By integrating multiomic data and modeling the tumor microenvironment, we help our partners optimize trial design, improve patient selection and accelerate the development of targeted therapies."
Each year, Frost & Sullivan presents this award to a company that has developed a breakthrough technology with the potential to significantly enhance existing products and enable the creation of new solutions and applications. The award highlights technologies with strong potential for market adoption and industry impact.
Frost & Sullivan Best Practices Awards honor companies across regional and global markets that demonstrate excellence in innovation, leadership, customer service and strategic product development. Recipients are selected through a rigorous evaluation process involving in-depth interviews, market analysis and extensive secondary research to identify companies that set the benchmark for industry best practices.
Read the final report here.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion .
Contact:
Ashley Shreve
Marketing Coordinator - Best Practices Recognition
[email protected]
Phone: +1.210.844.2505
About BostonGene Corporation
BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit www.BostonGene.com .For more information, visit www.BostonGene.com .
Contact:
Erin Keleher
[email protected]
Phone: +1-617-283-2285
SOURCE Frost & Sullivan
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
22 minutes ago
- Cision Canada
Frost & Sullivan Commends CHT Security's Cybersecurity Excellence with 2025 Taiwan Company of the Year Recognition
CHT Security is recognized for innovation, operational excellence, and customer-centric strategies that safeguard Taiwan's digital infrastructure. SAN ANTONIO , July 29, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that CHT Security Co., Ltd. has received the 2025 Taiwan Company of the Year Recognition in the cybersecurity services industry for its outstanding achievements in innovation, strategy execution, and client impact. This recognition highlights CHT Security's consistent leadership in delivering scalable, end-to-end cybersecurity solutions that enhance national cyber defense and enterprise digital resilience. CHT Security excels in its unique ability to align its cybersecurity strategy with market demand with speed, precision, and scale. "Frost & Sullivan recognizes CHT Security's full-service model, proprietary innovation, and commitment to underserved markets as a strategic approach that positions the company for long-term growth and relevance," said Vivien Pua , senior industry analyst at Frost & Sullivan. Backed by the infrastructure of Chunghwa Telecom, Taiwan's largest telecom provider, CHT Security has scaled rapidly by leveraging in-house innovation, cloud-based intelligence platforms, and AI-enhanced threat detection. Its long-term strategy integrates ESG principles, global certifications, and localized partnerships, ensuring service relevance across both high-impact sectors and underserved SMB segments in Taiwan and beyond. The company's innovation pipeline is anchored by platforms such as CypherCom, a hardware-based encryption solution that strengthens endpoint protection by isolating critical processes from compromised systems. Similarly, SecuTex ED and HorusEyes deliver real-time threat detection and scalable protection, bringing enterprise-grade cybersecurity within reach for smaller organizations. "Our mission is to make advanced cybersecurity not only powerful, but also practical and accessible — so that every organization, regardless of size, can protect what matters most." said Jeff Hung , General Manager at CHT Security. CHT Security's customer-first mindset is evident in its 24/7 multilingual support, biannual client feedback loops, and rapid on-site assistance. The company's focus on professionalism is underscored by rigorous internal assessments, government-aligned certifications, and a strong emphasis on staff training. This structured, responsive approach has fostered exceptional client loyalty, positioning CHT Security as a go-to provider for Taiwan's most sensitive public and private institutions. Frost & Sullivan commends CHT Security for setting a new benchmark in Taiwan's cybersecurity sector. From its strategic clarity and local responsiveness to its relentless focus on innovation, the company exemplifies what it means to lead with purpose and deliver with precision. Each year, Frost & Sullivan presents a Company of the Year recognition to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. This recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration. Frost & Sullivan Best Practices recognitions spotlight companies across global markets that demonstrate superior leadership, technological innovation, customer service, and strategic product development. Our research and evaluation methodology includes comprehensive interviews, analysis, and benchmarking to identify industry leaders setting the standard for excellence. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion . Contact: Tarini Singh E: [email protected] About CHT Security Headquartered in Taipei, Taiwan , CHT Security (TWSE: 7765) is a subsidiary of the Chunghwa Telecom Group, the first telco in Taiwan . CHT Security is ISO 27001, ISO 27701, ISO 20000, ISO 17025, and IEC 62443 CBTL certified. In the government's annual review, CHT Security is the only cybersecurity company to receive straight A top ratings for consecutive years. With extensive experience in cyber defense and robust R&D capabilities, CHT Security offers a full spectrum of cybersecurity services and solutions, including security testing, SOC monitoring, incident response, and digital forensics. Its clients span across sectors such as government, finance, healthcare, high-tech manufacturing, retail, and more. It has also expanded its international presence, providing services to clients in Southeast Asia (including Thailand , Vietnam , and Malaysia ), as well as in Americas and Europe . Contact: Karen Chen [email protected] SOURCE Frost & Sullivan
Cision Canada
20 hours ago
- Cision Canada
Wake Up Talks Coaching Launches Strategic Coaching Pathway to Help Introverted Midlife Women Reclaim Clarity and Confidence
The 12-week Authentic Self-Empowerment Framework offers a proven, structured method for introverted professional women to overcome internal stress, rediscover their purpose NEW YORK, July 28, 2025 /CNW/ -- Wake Up Talks Coaching, founded by accredited coach and former business strategist Simona Zajc, has officially launched the Authentic Self-Empowerment Pathway, a private, 12-week coaching experience specifically designed to support introverted professional women in midlife navigating emotional overwhelm, self-doubt, and transitions in identity or purpose. Simona, an ICF and EMCC certified coach, developed Strategic Mind Method to meet a widespread yet often unspoken need: the internal struggle many midlife women face as they quietly juggle professional responsibilities, family dynamics, and their own unmet aspirations. Unlike generalized life coaching, this program provides a structured, step-by-step process that supports personal clarity, calm, and actionable change from the inside out adhering to firm coaching standards. "As a former strategist turned coach, I've seen how many women silently struggle, questioning their direction while maintaining an outward calm," says Zajc. "This program meets them where they are—with tools that help shift the pressure and unlock clear, confident action." The need for such targeted coaching is backed by research: 47% of midlife women identify as introverts, making them more prone to internalized stress. Studies by Phoenix Insights and Ipsos, published in Actuarial Post, reveal that over 50% of women aged 45–55 feel "stuck" or unsure about how to move forward in life or career. Past clients of the program report a 50% increase in mental clarity, a 33% rise in calm, and significantly improved decision-making confidence. Each week of the program builds on the last, using private coaching, deep listening, and introspective exercises to guide participants toward self-awareness, values-based decision-making, and sustainable personal growth. By the end of 12 weeks, clients are equipped not only with insight but with actionable strategies to navigate their next chapter with renewed confidence. Enrollment is now open, with only five client spots available per month to ensure personalized support. Visit to learn more. Founded by Simona Zajc—ICF/EMCC-certified coach, former business strategist, and award-winning author— Wake Up Talks Coaching specializes in helping introverted midlife women overcome overwhelm and rediscover their authentic path. Through her signature Authentic Self-Empowerment Pathway, Simona offers structured, high-touch coaching for lasting clarity, calm, and confidence.
Cision Canada
a day ago
- Cision Canada
Siemens Healthineers Receives Frost & Sullivan's 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications
Recognized for delivering diagnostic innovation, workflow efficiency, and enterprise imaging leadership through advanced visualization solutions SAN ANTONIO, July 28, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Siemens Healthineers has been awarded the 2025 North America Company of the Year Recognition in the advanced visualization applications industry for its outstanding achievements in diagnostic innovation, seamless platform integration, and customer impact. This recognition underscores Siemens Healthineers' market leadership in transforming medical imaging with intelligent automation, scalable technology, and end-to-end workflow solutions. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation and customer impact. Siemens Healthineers excelled in both, demonstrating a compelling ability to align long-term product development with the evolving demands of healthcare systems while executing consistently across complex, high-stakes clinical environments. "By continuously translating real-world insights into high-performing solutions, Siemens Healthineers maintains its reputation as a preferred partner across global health systems," said Anantharaman Viswanathan, Research Director at Frost & Sullivan. Guided by a focused growth strategy centered on organic development, digital innovation, and deep customer partnerships, Siemens Healthineers shapes the future of advanced visualization (AV) by delivering scalable, integrated platforms that enhance diagnostic confidence and operational agility. The company's sustained investment in intelligent imaging software and adaptive workflow integration has enabled it to lead in a sector increasingly defined by complexity, interoperability, and performance at scale. At the core of Siemens Healthineers' AV leadership is its platform, which powers disease-specific, multi-modality applications for specialties such as radiology, oncology, neurology, and cardiology. Seamlessly integrated with the company's enterprise imaging backbone, Syngo Carbon, offers 3D and 4D visualization, AI-enabled segmentation, and robust quantitative analysis—all designed to empower clinicians to make fast and accurate decisions across the care continuum. The interoperability and modularity of this ecosystem distinguish it from fragmented solutions, allowing healthcare providers to standardize diagnostics, streamline data continuity, and reduce variability in interpretation. Innovation extends beyond clinical tools to include Siemens Healthineers' delivery model. Unlike competitors that rely on external acquisitions, the company offers a fully homegrown ecosystem, engineered for consistency, security, and adaptability. Shared digital workspaces enable multi-site collaboration, ensuring that radiologists, referring physicians, and entire care teams can access and interpret imaging results regardless of location. These collaborative capabilities are further supported by structured reporting tools and embedded clinical decision support, which help unify diagnostic standards and promote evidence-based practice. "We are honored to receive Frost & Sullivan's Company of the Year Award, which reflects our team's commitment to delivering meaningful innovation that drives clinical impact. Our advanced visualization portfolio empowers care teams with the tools they need to make efficient, more confident decisions across the entire patient journey," said Marcus da Silva, Head of Clinical and Efficiency Portfolio at Siemens Healthineers. "This recognition reinforces our mission to support health systems with scalable, intelligent solutions that enable better outcomes without compromise. The company's commitment to implementation excellence is equally compelling. Siemens Healthineers provides structured onboarding that aligns with each organization's infrastructure and workflow. Built-in education modules, role-specific training, and ongoing professional development ensure rapid user adoption and reduce technical overhead. By aligning its technology with how clinicians work, the company drives high utilization efficiency and long-term system value. Frost & Sullivan commends Siemens Healthineers for raising the bar in advanced visualization. By unifying clinical, operational, and financial priorities through a user-centric design philosophy, the company enables healthcare organizations to deliver improved patient outcomes—without compromise. Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: [email protected] About Siemens Healthineers Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at:
